Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations
Crossref DOI link: https://doi.org/10.1186/s40064-015-1233-y
Published Online: 2015-09-21
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nattinger, Ann Butler
Pezzin, Liliana E
McGinley, Emily L
Charlson, John A
Yen, Tina W F
Neuner, Joan M
Text and Data Mining valid from 2015-09-21
Version of Record valid from 2015-09-21
Article History
First Online: 21 September 2015